Management of platelet-inhibiting Therapy during Thrombocytopenia after autologous Stem Cell Transplantation in Patients with multiple Myeloma

被引：0
|
作者：
Bozhikova, Boryana [1 ]
Neuendorff, Nina Rosa [2 ]
Janssen, Maike
Jordan, Karin [3 ]
Mueller-Tidow, Carsten [3 ]
Goldschmidt, Hartmut [3 ]
Sauer, Sandra [3 ]
Rohde, Christian [3 ]
Kirchner, Marietta [4 ]
Frankenstein, Lutz [5 ]
Frey, Norbert [5 ]
机构：
[1] Stadt Klinikum Solingen Kardiol & allgemeine Inne, Solingen, Germany
[2] Univ Kilinikum Essen gGmbH, Klin Hamatol & Onkol, Essen, Germany
[3] Univ Klinikum Heidelberg, Klin Hamatol & Onkol, Heidelberg, Germany
[4] Univ Klinikum Heidelberg, Med Biometrie, Heidelberg, Germany
[5] Univ klinikum Heidelberg, Med Klin 3, Kardiol Klin, Heidelberg, Germany
来源：
INNERE MEDIZIN | 2024年 / 65卷
关键词：
LOW-DOSE ASPIRIN; ANTIPLATELET THERAPY; RISK; DISCONTINUATION; TRANSFUSION; PREVENTION; WITHDRAWAL; MALIGNANCIES; REVERSAL; IMPACT;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P16-08
引用
收藏
页码：S110 / S113
页数：4
相关论文
共 50 条
  • [21] Impact of MiRSNPs on Survival and Progression in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
    Fernandez de Larrea, Carlos
    Navarro, Alfons
    Tejero, Rut
    Tovar, Natalia
    Diaz, Tania
    Teresa Cibeira, Maria
    Rosinol, Laura
    Ferrer, Gerardo
    Rovira, Montserrat
    Rozman, Maria
    Monzo, Mariano
    Blade, Joan
    CLINICAL CANCER RESEARCH, 2012, 18 (13) : 3697 - 3704
  • [22] Autologous Hematopoietic Stem Cell Transplantation May Reverse Renal Failure in Patients with Multiple Myeloma
    Parikh, Gaurav C.
    Amjad, Ali Imran
    Saliba, Rima M.
    Kazmi, Syed M. A.
    Khan, Ziad U.
    Lahoti, Amit
    Hosing, Chitra
    Mendoza, Floralyn
    Qureshi, Suhail R.
    Weber, Donna M.
    Wang, Michael
    Popat, Uday
    Alousi, Amin M.
    Champlin, Richard E.
    Giralt, Sergio A.
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (07) : 812 - 816
  • [23] Unrelated stem cell transplantation for patients with multiple myeloma
    Kroeger, Nicolaus
    CURRENT OPINION IN HEMATOLOGY, 2010, 17 (06) : 538 - 543
  • [24] Analysis of early efficacy and immune reconstitution after autologous hematopoietic stem cell transplantation in multiple myeloma
    Chen, Kaili
    Liang, Huixin
    Yu, Zezhong
    Guo, Guangyao
    Zheng, Huijian
    Huang, Yun
    Liu, Liping
    Lin, Jie
    Long, Jinlan
    Pan, Renyao
    Chen, Xi
    Wang, Changgui
    Zhang, Wenjie
    Xu, Zhenshu
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [25] Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
    Yarlagadda, Lakshmi
    Gundarlapalli, Sravani
    Parikh, Richa
    Landes, Reid D.
    Kottarathara, Mathew
    Ogunsesan, Yetunde
    Hoque, Shadiqul
    Mitma, Angel A.
    Bailey, Clyde
    Hill, Kerri M.
    Thanendrarajan, Sharmilan
    Graziutti, Monica
    Mohan, Meera
    Zangari, Maurizio
    van Rhee, Frits
    Tricot, Guido
    Schinke, Carolina
    CANCERS, 2021, 13 (16)
  • [26] A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation
    Guo, Wancheng
    Strouse, Christopher
    Mery, David
    Siegel, Eric R.
    Munshi, Manit N.
    Ashby, Timothy Cody
    Cheng, Yan
    Sun, Fumou
    Wanchai, Visanu
    Zhang, Zijun
    Bailey, Clyde
    Alapat, Daisy V.
    Peng, Hongling
    Al Hadidi, Samer
    Thanendrarajan, Sharmilan
    Schinke, Carolina
    Zangari, Maurizio
    van Rhee, Frits
    Tricot, Guido
    Shaughnessy Jr, John D.
    Zhan, Fenghuang
    CANCERS, 2024, 16 (06)
  • [27] Risk factors of early disease progression and decreased survival for multiple myeloma patients after upfront autologous stem cell transplantation
    Hsu, Te-Lin
    Tsai, Chun-Kuang
    Liu, Chun-Yu
    Yeh, Chiu-Mei
    Lin, Fen-Lan
    Hsiao, Liang-Tsai
    Liu, Yao-Chung
    Chien, Sheng-Hsuan
    Wang, Hao-Yuan
    Ko, Po-Shen
    Lin, Ting-An
    Chen, Wen-Chun
    Chen, Po-Min
    Liu, Jin-Hwang
    Gau, Jyh-Pyng
    Liu, Chia-Jen
    ANNALS OF HEMATOLOGY, 2024, 103 (08) : 2893 - 2904
  • [28] Polyclonal Immunoglobulin Recovery after Autologous Stem Cell Transplantation Is an Independent Prognostic Factor for Survival Outcome in Patients with Multiple Myeloma
    Ozaki, Shuji
    Harada, Takeshi
    Yagi, Hikaru
    Sekimoto, Etsuko
    Shibata, Hironobu
    Shigekiyo, Toshio
    Fujii, Shiro
    Nakamura, Shingen
    Miki, Hirokazu
    Kagawa, Kumiko
    Abe, Masahiro
    CANCERS, 2020, 12 (01)
  • [29] Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Therapies
    Parrondo, Ricardo D.
    Ailawadhi, Sikander
    Sher, Taimur
    Chanan-Khan, Asher A.
    Roy, Vivek
    JCO ONCOLOGY PRACTICE, 2020, 16 (02) : 56 - +
  • [30] Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
    Takamatsu, Hiroyuki
    Yamashita, Takeshi
    Kurahashi, Shingo
    Saitoh, Takayuki
    Kondo, Tadakazu
    Maeda, Takeshi
    Nakazawa, Hideyuki
    Murata, Makoto
    Narita, Tomoko
    Kuroda, Junya
    Hashimoto, Hisako
    Kawamura, Koji
    Miyamoto, Toshihiro
    Honda, Sumihisa
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Sunami, Kazutaka
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03) : 474 - 479
12345